Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: The efficacy and safety of peripheral intravenous parenteral nutrition vs 10% glucose in preterm infants born 30 to 33 weeks’ gestation: a randomised controlled trial

Variable

P-PN (n = 42)

Control (n = 50)

Infant characteristics

 Female sex

17 (40)

17 (34)

 Gestational age, median (IQR), wks

32 (31–32)

32 (31–33)

 30+ 0–31+ 6 weeks’ gestation

15 (36)

19 (38)

 32+ 0–33+ 6 weeks’ gestation

27 (64)

31 (62)

 Singleton

18 (43)

32 (64)

 Twins

18 (43)

15 (30)

 Triplets

6 (14)

3 (6)

 Apgar at 5 min, median (IQR) (n = 41/50)

9.0 (8.0–9.0)

8.5 (8.0–9.0)

 Birth weight, mean (SD), g

1717 (289)

1749 (329)

  Birth weight z-score, mean (SD)

−0.2 (0.7)

−0.1 (0.7)

 Birth length, mean (SD), cm

42 (2)

42 (2)

 Birth head circumference, mean (SD), cm

30 (2)

30 (2)

Maternal characteristics

 Maternal age, mean (SD), yr

32 (5)

31 (5)

 Vaginal birth

14 (33)

15 (30)

 Caesarean section

28 (67)

35 (70)

 Antenatal steroids - any

24 (57)

35 (70)

  1. Data are presented as n (%) unless otherwise indicated